Feeds › Lobbying
Lobbying
Who pays Washington lobbyists, how much, and on which issues.
About this data
- What it is
- Companies and trade groups that pay for lobbying must report it to Congress every quarter: who they hired, how much they spent, and which issues were lobbied.
- Who files it
- The lobbying firm, or the company itself when it uses its own staff, under the Lobbying Disclosure Act.
- How current
- Quarterly reports are due 20 days after each quarter ends, so they arrive in waves. We collect them daily.
- Worth knowing
- Amounts are rounded by the filer and cover the whole quarter. We match clients to listed companies automatically, so a few may be missed or misattributed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Lobbying filings per day, last 30 days
All filings Of listed companies
Quarterly reports are due 20 days after each quarter ends, so filings come in waves.
Latest lobbying filings
Showing: ticker PFE
| Posted | Client | Lobbying firm | Report | AmountWhen a company hires a lobbying firm, the firm reports the income it received. When the company lobbies with its own staff, it reports its expenses instead. | Issues | Filing |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | PFE Pfizer, Inc. | Marshall & Popp, LLC | 2026 third quarter | $60.0K | PHA, CPT, TRD, TAX | LDA ↗ |
| Oct 20, 2026 | PFE Pfizer, Inc. | The Duberstein Group Inc. | 2026 third quarter | $60.0K | HCR, TRD | LDA ↗ |
| Oct 20, 2026 | PFE Pfizer, Inc. | Williams and Jensen, PLLC | 2026 third quarter | $60.0K | BUD, DEF, HCR, TAX | LDA ↗ |
| Oct 20, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2026 third quarter | $3.6M | HCR, MMM, TRD | LDA ↗ |
| Oct 20, 2026 | PFE Pfizer, Inc. | Miller Strategies, LLC | 2026 third quarter | $150.0K | MMM, HCR, TAX, LBR | LDA ↗ |
| Oct 20, 2026 | PFE Pfizer, Inc. | Federal Health Policy Strategies | 2026 third quarter | $60.0K | HCR | LDA ↗ |
| Oct 20, 2026 | PFE Pfizer, Inc. | BGR Government Affairs | 2026 third quarter | $60.0K | HCR | LDA ↗ |
| Oct 20, 2026 | PFE Pfizer, Inc. | Akin Gump Strauss Hauer & Feld | 2026 third quarter | $50.0K | LDA ↗ | |
| Oct 20, 2026 | PFE Pfizer, Inc. | Resolution Public Affairs, LLC | 2026 third quarter | $60.0K | HCR, MMM | LDA ↗ |
| Oct 19, 2026 | PFE Pfizer, Inc. | Todd Strategy Group | 2026 third quarter | $60.0K | PHA, MMM | LDA ↗ |
| Oct 16, 2026 | PFE Pfizer, Inc. | The Washington Tax & Public Policy Group | 2026 third quarter | — | TAX | LDA ↗ |
| Oct 13, 2026 | PFE Pfizer, Inc. | Altrius Group, LLC | 2026 third quarter | — | LDA ↗ | |
| Oct 8, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2026 first quarter | $4.4M | CPT, HCR, MMM, TRD | LDA ↗ |
| Aug 3, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2025 fourth quarter | $1.8M | HCR, MMM, TRD | LDA ↗ |
| Jul 21, 2026 | PFE Pfizer, Inc. | Todd Strategy Group | 2026 second quarter | $60.0K | PHA, TAR, TRD | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | Williams and Jensen, PLLC | 2026 second quarter | $60.0K | TRD, BUD, DEF, HCR | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | Miller Strategies, LLC | 2026 second quarter | $150.0K | MMM, HCR, TAX, LBR | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2026 second quarter | $1.9M | CPT, HCR, MMM, TAX | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | The Washington Tax & Public Policy Group | 2026 second quarter | — | TAX | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | Federal Health Policy Strategies | 2026 second quarter | $60.0K | HCR | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | The Duberstein Group Inc. | 2026 second quarter | $60.0K | BUD, HCR | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | BGR Government Affairs | 2026 second quarter | $60.0K | HCR | LDA ↗ |
| Jul 20, 2026 | PFE Pfizer, Inc. | Akin Gump Strauss Hauer & Feld | 2026 second quarter | $50.0K | LDA ↗ | |
| Jul 19, 2026 | PFE Pfizer, Inc. | Resolution Public Affairs, LLC | 2026 second quarter | $60.0K | HCR, MMM | LDA ↗ |
| Jul 11, 2026 | PFE Pfizer, Inc. | Altrius Group, LLC | 2026 second quarter | — | LDA ↗ | |
| Jul 9, 2026 | PFE Pfizer, Inc. | Marshall & Popp, LLC | 2026 second quarter | $60.0K | PHA, CPT, TRD, TAX | LDA ↗ |
| Apr 20, 2026 | PFE Pfizer, Inc. | Todd Strategy Group | 2026 first quarter | $60.0K | PHA, TAR, TRD | LDA ↗ |
| Apr 20, 2026 | PFE Pfizer, Inc. | Resolution Public Affairs, LLC | 2026 first quarter | $60.0K | HCR, MMM | LDA ↗ |
| Apr 20, 2026 | PFE Pfizer, Inc. | The Duberstein Group Inc. | 2026 first quarter | $60.0K | BUD, HCR | LDA ↗ |
| Apr 20, 2026 | PFE Pfizer, Inc. | Miller Strategies, LLC | 2026 first quarter | $150.0K | MMM, HCR, TAX, LBR | LDA ↗ |
| Apr 20, 2026 | PFE Pfizer, Inc. | Williams and Jensen, PLLC | 2026 first quarter | $60.0K | HCR, TAX, MMM, TRD | LDA ↗ |
| Apr 20, 2026 | PFE Pfizer, Inc. | BGR Government Affairs | 2026 first quarter | $60.0K | HCR | LDA ↗ |
| Apr 20, 2026 | PFE Pfizer, Inc. | Akin Gump Strauss Hauer & Feld | 2026 first quarter | $50.0K | LDA ↗ | |
| Apr 20, 2026 | PFE Pfizer, Inc. | Federal Health Policy Strategies | 2026 first quarter | $60.0K | HCR | LDA ↗ |
| Apr 18, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2026 first quarter | $4.4M | CPT, HCR, MMM, TRD | LDA ↗ |
| Apr 17, 2026 | PFE Pfizer, Inc. | Marshall & Popp, LLC | 2026 first quarter | $60.0K | TRD, TAX, PHA, CPT | LDA ↗ |
| Apr 13, 2026 | PFE Pfizer, Inc. | Altrius Group, LLC | 2026 first quarter | — | LDA ↗ | |
| Apr 2, 2026 | PFE Pfizer, Inc. | The Washington Tax & Public Policy Group | 2026 first quarter | $110.0K | TAX | LDA ↗ |
| Mar 17, 2026 | PFE Pfizer, Inc. | Todd Strategy Group | 2025 fourth quarter | $60.0K | PHA, TAR, TRD | LDA ↗ |
| Mar 17, 2026 | PFE Pfizer, Inc. | Todd Strategy Group | 2025 third quarter | $60.0K | PHA, TAR, TRD | LDA ↗ |
| Mar 17, 2026 | PFE Pfizer, Inc. | Todd Strategy Group | 2025 second quarter | $20.0K | PHA, TAR, TRD | LDA ↗ |
| Mar 17, 2026 | PFE Pfizer, Inc. | Todd Strategy Group | 2025 second quarter | — | PHA, TAR, TRD | LDA ↗ |
| Mar 12, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2025 third quarter | $2.9M | HCR, MMM, TRD | LDA ↗ |
| Mar 12, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2025 fourth quarter | $1.8M | HCR, MMM, TRD | LDA ↗ |
| Jan 23, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2025 third quarter | $2.8M | HCR, MMM, TRD | LDA ↗ |
| Jan 20, 2026 | PFE Pfizer, Inc. | The Duberstein Group Inc. | 2025 fourth quarter | $60.0K | LDA ↗ | |
| Jan 20, 2026 | PFE Pfizer, Inc. | Williams and Jensen, PLLC | 2025 fourth quarter | $60.0K | HCR, TAX, MMM, TRD | LDA ↗ |
| Jan 20, 2026 | PFE Pfizer, Inc. | Miller Strategies, LLC | 2025 fourth quarter | $120.0K | MMM, HCR, TAX, LBR | LDA ↗ |
| Jan 20, 2026 | PFE Pfizer, Inc. | Resolution Public Affairs, LLC | 2025 fourth quarter | $60.0K | HCR | LDA ↗ |
| Jan 20, 2026 | PFE Pfizer, Inc. | Pfizer Inc. | 2025 fourth quarter | $1.7M | HCR, MMM, TRD | LDA ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 4:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances